Carl D’Ruiz, MPH

Carl D’Ruiz is a recognized leader in photoprotection, championing sun protection, skin cancer prevention, and holistic skin wellness for over 30 years. As Head of North America Beauty & Care Business Development at dsm-firmenich, he merges cutting-edge science with real-world solutions to advance skin health.
A Yale-trained public health professional, Carl is currently pursuing FDA approval for the first new sunscreen filter in 26 years—through DSM’s OMOR submission for PARSOL® Shield (Bemotrizinol)—and advocates for U.S. sunscreen innovation via modern non-animal testing and risk assessment approaches. He supports The Skin Cancer Foundation’s free screening initiatives and serves on industry committees shaping regulatory standards.
Through dsm-firmenich’s Design2Market program, Carl leverages cutting-edge innovations—senolytics, exosomes, NAD+ modulators, neurocosmetics, and dermo-cosmetics—to deliver clinically backed solutions. From photoprotection and longevity to barrier resilience, hydration, and hyperpigmentation, he drives science-powered advancements that meet the evolving needs of dermatologists and modern skincare.